Article
WITHDRAWN: GATA2 promotes castration-resistant prostate cancer development by suppressing IFN-β axis-mediated antitumor immunity
2024-02-23
Abstract excerpt
<title>Abstract</title> <p> Castration-resistant prostate cancer (CRPC) nearly inevitably develops after long-term treatment with androgen deprivation therapy (ADT), leading to significant mortality. Investigating the mechanisms driving CRPC development is imperative. Here, we determined that the pioneer transcription factor <italic>GATA2</italic> , which is frequently amplified in CRPC patients, inhibits inte...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 86f6cd3d-8389-5c76-bf38-479ddbfb04cc
- DOI
- 10.21203/rs.3.rs-3958845/v1
